As per corporate shareholdings filed for Jan-2025, people matching Hanwha Global Healthcare Master Equity publicly holds 77 stocks with a net worth of over US$ 121.6 M.
These are shares held by Hanwha Global Healthcare Master Equity as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
---|---|---|---|---|---|---|---|---|
Agiliti Inc | Hanwha Global Healthcare Master Equity | 10.05 | 78,590 | 0.06% | 0.00 | 789.8 K | ||
Apellis Pharmaceuticals Inc | Hanwha Global Healthcare Master Equity | 23.79 | 14,000 | 0.01% | 0.00 | 333.1 K | ||
DocGo Inc | Hanwha Global Healthcare Master Equity | 2.78 | 99,880 | 0.10% | 0.00 | 277.7 K | ||
Galera Therapeutics Inc | Hanwha Global Healthcare Master Equity | 0.04 | 425,913 | 0.97% | 0.00 | 17.0 K | ||
Healthequity Inc | Hanwha Global Healthcare Master Equity | 89.22 | 39,359 | 0.05% | 0.00 | 3.5 M | ||
Mirati Therapeutics Inc | Hanwha Global Healthcare Master Equity | 58.70 | 26,250 | 0.04% | 0.00 | 1.5 M | ||
Rain Oncology Inc | Hanwha Global Healthcare Master Equity | 1.78 | 120,344 | 0.33% | 0.00 | 214.2 K | ||
R1 RCM Inc. | Hanwha Global Healthcare Master Equity | 52.00 | 106,116 | 0.03% | 0.00 | 5.5 M | ||
Seagen Inc | Hanwha Global Healthcare Master Equity | 228.88 | 7,250 | 0.00% | 0.00 | 1.7 M | ||
Silk Road Medical Inc | Hanwha Global Healthcare Master Equity | 27.49 | 45,500 | 0.12% | 0.00 | 1.3 M | ||
ShockWave Medical Inc | Hanwha Global Healthcare Master Equity | 0.00 | 6,300 | 0.02% | 0.00 | - | ||
TELA Bio Inc | Hanwha Global Healthcare Master Equity | 1.29 | 120,000 | 0.49% | 0.00 | 154.8 K | ||
Treace Medical Concepts Inc | Hanwha Global Healthcare Master Equity | 8.58 | 75,974 | 0.12% | 0.00 | 651.9 K | ||
2seventy bio Inc | Hanwha Global Healthcare Master Equity | 4.96 | 107,162 | 0.21% | 0.00 | 531.5 K | ||
Conmed Corp. | Hanwha Global Healthcare Master Equity | 60.35 | 10,000 | 0.03% | 0.00 | 603.5 K | ||
Axonics Inc | Hanwha Global Healthcare Master Equity | 70.98 | 18,000 | 0.04% | 0.00 | 1.3 M | ||
Graphite Bio Inc | Hanwha Global Healthcare Master Equity | 50.00 | 196,568 | 0.34% | 0.00 | 9.8 M | ||
Iovance Biotherapeutics Inc | Hanwha Global Healthcare Master Equity | 3.44 | 109,618 | 0.04% | 0.00 | 377.1 K | ||
Prothena Corporation plc | Hanwha Global Healthcare Master Equity | 13.37 | 22,598 | 0.04% | 0.00 | 302.1 K | ||
Privia Health Group Inc | Hanwha Global Healthcare Master Equity | 22.88 | 55,117 | 0.05% | 0.00 | 1.3 M | ||
Syndax Pharmaceuticals Inc | Hanwha Global Healthcare Master Equity | 13.13 | 50,000 | 0.06% | 0.00 | 656.5 K | ||
EyePoint Pharmaceuticals Inc | Hanwha Global Healthcare Master Equity | 6.06 | 41,492 | 0.06% | 0.00 | 251.4 K | ||
MoonLake Immunotherapeutics - Ordinary Shares - Class A | Hanwha Global Healthcare Master Equity | 38.39 | 22,167 | 0.04% | 0.00 | 851.0 K | ||
Altimmune Inc | Hanwha Global Healthcare Master Equity | 5.59 | 36,000 | 0.05% | 0.00 | 201.2 K | ||
Arvinas Inc | Hanwha Global Healthcare Master Equity | 7.95 | 21,000 | 0.03% | 0.00 | 167.0 K | ||
Boundless Bio Inc. | Hanwha Global Healthcare Master Equity | 1.52 | 73,374 | 0.33% | 0.00 | 111.5 K | ||
Cogent Biosciences Inc | Hanwha Global Healthcare Master Equity | 6.47 | 125,000 | 0.11% | 0.00 | 808.8 K | ||
Acelyrin Inc | Hanwha Global Healthcare Master Equity | 2.54 | 120,000 | 0.12% | 0.00 | 304.8 K | ||
Vera Therapeutics Inc - Ordinary Shares - Class A | Hanwha Global Healthcare Master Equity | 25.91 | 19,494 | 0.03% | 0.00 | 505.1 K | ||
Verastem Inc | Hanwha Global Healthcare Master Equity | 6.40 | 25,000 | 0.06% | 0.00 | 160 K | ||
LENZ Therapeutics Inc. | Hanwha Global Healthcare Master Equity | 26.09 | 47,557 | 0.17% | 0.00 | 1.2 M | ||
Align Technology, Inc. | Hanwha Global Healthcare Master Equity | 166.46 | 1,000 | 0.00% | 0.00 | 166.5 K | ||
Baxter International Inc. | Hanwha Global Healthcare Master Equity | 33.36 | 7,000 | 0.00% | 0.00 | 233.5 K | ||
Biogen Inc | Hanwha Global Healthcare Master Equity | 142.43 | 2,000 | 0.00% | 0.00 | 284.9 K | ||
Biomarin Pharmaceutical Inc. - Registered Shares | Hanwha Global Healthcare Master Equity | 71.48 | 3,650 | 0.00% | 0.00 | 260.9 K | ||
Cardinal Health, Inc. | Hanwha Global Healthcare Master Equity | 133.98 | 3,300 | 0.00% | 0.00 | 442.1 K | ||
Centene Corp. | Hanwha Global Healthcare Master Equity | 60.54 | 7,000 | 0.00% | 0.00 | 423.8 K | ||
CVS Health Corp | Hanwha Global Healthcare Master Equity | 67.20 | 17,000 | 0.00% | 0.00 | 1.1 M | ||
Quest Diagnostics, Inc. | Hanwha Global Healthcare Master Equity | 166.62 | 1,500 | 0.00% | 0.00 | 249.9 K | ||
Dexcom Inc | Hanwha Global Healthcare Master Equity | 72.13 | 6,550 | 0.00% | 0.00 | 472.5 K | ||
Edwards Lifesciences Corp | Hanwha Global Healthcare Master Equity | 71.09 | 8,800 | 0.00% | 0.00 | 625.6 K | ||
Hologic, Inc. | Hanwha Global Healthcare Master Equity | 61.48 | 3,000 | 0.00% | 0.00 | 184.4 K | ||
Humana Inc. | Hanwha Global Healthcare Master Equity | 270.48 | 1,570 | 0.00% | 0.00 | 424.7 K | ||
Idexx Laboratories, Inc. | Hanwha Global Healthcare Master Equity | 417.71 | 1,100 | 0.00% | 0.00 | 459.5 K | ||
Illumina Inc | Hanwha Global Healthcare Master Equity | 82.83 | 2,200 | 0.00% | 0.00 | 182.2 K | ||
Moderna Inc | Hanwha Global Healthcare Master Equity | 31.48 | 3,400 | 0.00% | 0.00 | 107.0 K | ||
Agilent Technologies Inc. | Hanwha Global Healthcare Master Equity | 119.90 | 4,000 | 0.00% | 0.00 | 479.6 K | ||
Abbvie Inc | Hanwha Global Healthcare Master Equity | 201.30 | 32,106 | 0.00% | 0.00 | 6.5 M | ||
Abbott Laboratories | Hanwha Global Healthcare Master Equity | 126.61 | 27,424 | 0.00% | 0.00 | 3.5 M | ||
Alcon Inc. - Registered Shares | Hanwha Global Healthcare Master Equity | 91.32 | 7,000 | 0.00% | 0.00 | 639.2 K | ||
Alnylam Pharmaceuticals Inc | Hanwha Global Healthcare Master Equity | 269.21 | 2,000 | 0.00% | 0.00 | 538.4 K | ||
AMGEN Inc. | Hanwha Global Healthcare Master Equity | 305.71 | 7,914 | 0.00% | 0.00 | 2.4 M | ||
Argen X SE - ADR | Hanwha Global Healthcare Master Equity | 583.66 | 870 | 0.00% | 0.00 | 507.8 K | ||
Becton, Dickinson And Co. | Hanwha Global Healthcare Master Equity | 228.00 | 4,381 | 0.00% | 0.00 | 998.9 K | ||
Bristol-Myers Squibb Co. | Hanwha Global Healthcare Master Equity | 59.21 | 68,149 | 0.00% | 0.00 | 4.0 M | ||
Boston Scientific Corp. | Hanwha Global Healthcare Master Equity | 102.34 | 42,421 | 0.00% | 0.00 | 4.3 M | ||
Cigna Group (The) | Hanwha Global Healthcare Master Equity | 321.23 | 5,450 | 0.00% | 0.00 | 1.8 M | ||
Danaher Corp. | Hanwha Global Healthcare Master Equity | 210.41 | 11,288 | 0.00% | 0.00 | 2.4 M | ||
Elevance Health Inc | Hanwha Global Healthcare Master Equity | 430.53 | 3,150 | 0.00% | 0.00 | 1.4 M | ||
GE HealthCare Technologies Inc | Hanwha Global Healthcare Master Equity | 81.00 | 6,000 | 0.00% | 0.00 | 486 K | ||
Gilead Sciences, Inc. | Hanwha Global Healthcare Master Equity | 109.27 | 17,000 | 0.00% | 0.00 | 1.9 M | ||
HCA Healthcare Inc | Hanwha Global Healthcare Master Equity | 337.29 | 2,600 | 0.00% | 0.00 | 877.0 K | ||
Innoviva Inc | Hanwha Global Healthcare Master Equity | 17.42 | 170,642 | 0.27% | 0.06 | 3.0 M | ||
IQVIA Holdings Inc | Hanwha Global Healthcare Master Equity | 180.02 | 2,550 | 0.00% | 0.00 | 459.1 K | ||
Intuitive Surgical Inc | Hanwha Global Healthcare Master Equity | 509.03 | 9,681 | 0.00% | 0.00 | 4.9 M | ||
Johnson & Johnson | Hanwha Global Healthcare Master Equity | 161.72 | 41,279 | 0.00% | 0.00 | 6.7 M | ||
Lilly(Eli) & Co | Hanwha Global Healthcare Master Equity | 826.76 | 12,026 | 0.00% | 0.00 | 9.9 M | ||
Mckesson Corporation | Hanwha Global Healthcare Master Equity | 663.02 | 2,896 | 0.00% | 0.00 | 1.9 M | ||
Medtronic Plc | Hanwha Global Healthcare Master Equity | 88.23 | 27,548 | 0.00% | 0.00 | 2.4 M | ||
Merck & Co Inc | Hanwha Global Healthcare Master Equity | 88.11 | 37,476 | 0.00% | 0.00 | 3.3 M | ||
Mettler-Toledo International, Inc. | Hanwha Global Healthcare Master Equity | 1191.03 | 300 | 0.00% | 0.00 | 357.3 K | ||
Pfizer Inc. | Hanwha Global Healthcare Master Equity | 25.21 | 41,414 | 0.00% | 0.00 | 1.0 M | ||
Regeneron Pharmaceuticals, Inc. | Hanwha Global Healthcare Master Equity | 640.14 | 1,500 | 0.00% | 0.00 | 960.2 K | ||
Stryker Corp. | Hanwha Global Healthcare Master Equity | 367.77 | 5,619 | 0.00% | 0.00 | 2.1 M | ||
Thermo Fisher Scientific Inc. | Hanwha Global Healthcare Master Equity | 513.67 | 6,057 | 0.00% | 0.00 | 3.1 M | ||
Unitedhealth Group Inc | Hanwha Global Healthcare Master Equity | 518.20 | 13,172 | 0.00% | 0.00 | 6.8 M | ||
Zoetis Inc - Ordinary Shares - Class A | Hanwha Global Healthcare Master Equity | 162.82 | 6,000 | 0.00% | 0.00 | 976.9 K | ||
Vertex Pharmaceuticals, Inc. | 500.28 | - | Investor holds below 1% |